Finance
Results: 26317-26328 of 49953

UK Medicines and Healthcare Products Regulatory Agency has Validated and Accepted the Marketing Authorization Application for ADL-018, a Proposed Biosimilar of Xolair® (omalizumab)

Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States

Karbon-X Partners with Zodiac Gold to Integrate Carbon Offsets into Exploration Efforts in West Africa








